Stable lentiviral vector production cell lines yield LVV titres comparable to the four-plasmid process

被引：0

作者：

Tridgett, M. ^{[1
]}

Mulet, M. ^{[1
]}

Raghunath, M. ^{[1
]}

Johny, S. Parokkaran ^{[1
]}

Ababi, M. ^{[1
]}

Beveridge, R. ^{[1
]}

Salkauskaite, I. ^{[1
]}

Fustinoni, C. ^{[1
]}

Peckett, M. ^{[1
]}

Kent, J. ^{[1
]}

Montgomery, L. ^{[1
]}

Asatryan, R. ^{[1
]}

Warelow, T. ^{[1
]}

Merritt, T. ^{[1
]}

Ballard, C. ^{[1
]}

Pahita, E. ^{[1
]}

Fernandez-Diaz, C. ^{[1
]}

White, M. ^{[1
]}

Parker-Manuel, R. ^{[1
]}

Dong, Y. ^{[2
]}

Jiang, M. ^{[2
]}

Cawood, R. ^{[1
]}

Branciaroli, C. ^{[1
]}

Patricio, M. I. ^{[1
]}

Liu, Q.

机构：

[1] Oxford Genet Ltd, Oxford, England

[2] WuXi Adv Therapies, Philadelphia, PA USA

来源：

HUMAN GENE THERAPY | 2024年 / 35卷 / 3-4期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

P246

引用

页码：A125 / A125

页数：1

共 50 条

[31] Continuous Perfusion with a Stable Producer HEK293 Cell Line for Scaling Up Lentiviral Vector Production
Cattaneo, Maurizio
Rodenbrock, Anja
Lanthier, Stephane
Burney, Elodie
Spanjaard, Remco
Manceur, Aziza
MOLECULAR THERAPY, 2020, 28 (04) : 432 - 432
[32] Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line
Stibbs, Dale J.
Couto, Pedro Silva
Takeuchi, Yasuhiro
Rafiq, Qasim A.
Jackson, Nigel B.
Rayat, Andrea C. M. E.
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (02)
[33] Pushing the right buttons: genetic silencing in producing cell lines to boost lentiviral vector production led to metabolic disfunction counteracting vector requirements
Lopez, C.
Yubero, M. E.
Arbelaiz, A.
Ramirez, J. C.
Albo, C.
HUMAN GENE THERAPY, 2021, 32 (19-20) : A114 - A115
[34] Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures
Ansorge, Sven
Lanthier, Stephane
Transfiguracion, Julia
Durocher, Yves
Henry, Olivier
Kamen, Amine
JOURNAL OF GENE MEDICINE, 2009, 11 (10): : 868 - 876
[35] DEVELOPING A SCALABLE, CHEMICALLY-DEFINED LENTIVIRAL VECTOR PRODUCTION PROCESS FOR GENE-MODIFIED CELL THERAPIES
Fiol, C. Ripoll
Collignon, M.
Welsh, J.
Rafiq, Q. A.
CYTOTHERAPY, 2023, 25 (06) : S268 - S268
[36] Using a cell receptor knock-out strategy to enable stable expression of cytotoxic envelope glycoproteins for lentiviral vector production
Nogueira, R.
Rodrigues, A. F.
Coroadinha, A. S.
HUMAN GENE THERAPY, 2024, 35 (3-4) : A123 - A123
[37] Recombinant adeno-associated viral vector production using stable packaging and producer cell lines
Mathews, LC
Gray, JT
Gallagher, MR
Snyder, RO
GENE THERAPY METHODS, 2002, 346 : 393 - 413
[38] Next Generation Adeno Helper Plasmids and Helper Stable Cell Lines for Efficient AAV Vector Production
Doshi, Jiten
Couto, Emma
Staiti, Jillian
Vandenberghe, Luk H.
Zabaleta, Nerea
MOLECULAR THERAPY, 2024, 32 (04) : 156 - 156
[39] Rapid protein production from stable CHO cell pools using plasmid vector and the cumate gene-switch
Poulain, Adeline
Perret, Sylvie
Malenfant, Felix
Mullick, Alaka
Massie, Bernard
Durocher, Yves
JOURNAL OF BIOTECHNOLOGY, 2017, 255 : 16 - 27
[40] Cell- and vector-engineering approaches for manufacturing high-titer GaLV pseudotyped lentiviral vectors from stable and constitutive producer cell lines
Rodrigues, A. F.
Nogueira, R.
Vaz, T. A.
Carrondo, M. J. T.
Coroadinha, A. S.
HUMAN GENE THERAPY, 2019, 30 (11) : A4 - A5

← 1 2 3 4 5 →